Cargando…

Editorial: Genetics of familial hypercholesterolemia: New insight—Volume II

Detalles Bibliográficos
Autores principales:	Vuorio, Alpo, Ramaswami, Uma, Holven, Kirsten B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597627/ https://www.ncbi.nlm.nih.gov/pubmed/36313446 http://dx.doi.org/10.3389/fgene.2022.1041342

Ejemplares similares

Editorial: Genetics of Familial Hypercholesterolemia: New Insight
por: Vuorio, Alpo, et al.
Publicado: (2021)

Genetics of Familial Hypercholesterolemia: New Insights
por: Vrablik, Michal, et al.
Publicado: (2020)

Prevention of endothelial dysfunction and thrombotic events in COVID-19 patients with familial hypercholesterolemia
por: Vuorio, Alpo, et al.
Publicado: (2020)

Decreasing the Cholesterol Burden in Heterozygous Familial Hypercholesterolemia Children by Dietary Plant Stanol Esters
por: Vuorio, Alpo, et al.
Publicado: (2018)

Familial hypercholesterolemia and statins in the COVID-19 era: Mitigating the risk of ischemic stroke
por: Vuorio, Alpo, et al.
Publicado: (2021)

Hospitalized Children With Familial Hypercholesterolemia and COVID-19: A Case for Preventive Anticoagulation
por: Vuorio, Alpo, et al.
Publicado: (2021)

Opportunities for preventing further endothelial dysfunction in pregnant COVID-19 patients with familial hypercholesterolemia
por: Vuorio, Alpo, et al.
Publicado: (2022)

The risk of various types of cardiovascular diseases in mutation positive familial hypercholesterolemia; a review
por: Hovland, Anders, et al.
Publicado: (2022)

Why continued lipoprotein apheresis is vital for homozygous familial hypercholesterolemia patients with COVID-19
por: Vuorio, Alpo, et al.
Publicado: (2021)

Patients with familial hypercholesterolemia and COVID-19: Efficient and ongoing cholesterol lowering is paramount for the prevention of acute myocardial infarction
por: Kovanen, Petri T., et al.
Publicado: (2021)

Genetics of Hypercholesterolemia: Comparison Between Familial Hypercholesterolemia and Hypercholesterolemia Nonrelated to LDL Receptor
por: Jarauta, Estíbaliz, et al.
Publicado: (2020)

Inhibition of hepatic microsomal triglyceride transfer protein – a novel therapeutic option for treatment of homozygous familial hypercholesterolemia
por: Vuorio, Alpo, et al.
Publicado: (2014)

Familial hypercholesterolemia and COVID-19: A menacing but treatable vasculopathic condition
por: Vuorio, Alpo, et al.
Publicado: (2021)

Long-Term Cardiovascular and Cerebrovascular Challenges Posed by COVID-19 in Patients With Familial Hypercholesterolemia
por: Vuorio, Alpo, et al.
Publicado: (2022)

Hypercholesterolemia and COVID-19: Statins for Lowering the Risk of Venous Thromboembolism
por: Vuorio, Alpo, et al.
Publicado: (2021)

Prevention of Cardiovascular Burden in COVID-19 Patients Suffering from Familial Hypercholesterolemia: A Global Challenge
por: Vuorio, Alpo, et al.
Publicado: (2021)

Genetic Diagnosis of Familial Hypercholesterolemia in Asia
por: Huang, Chin-Chou, et al.
Publicado: (2020)

Genetics, Screening, and Treatment of Familial Hypercholesterolemia: Experience Gained From the Implementation of the Vietnam Familial Hypercholesterolemia Registry
por: Truong, Thanh-Huong, et al.
Publicado: (2020)

Cholesterol-lowering drugs for high-risk hypercholesterolemia patients with COVID-19 while on Paxlovid™ therapy
por: Vuorio, Alpo, et al.
Publicado: (2022)

Compliance of the aorta in two diseases affecting vascular elasticity, familial hypercholesterolemia and diabetes: a MRI study
por: Soljanlahti, Sami, et al.
Publicado: (2008)

Editorial: Genetics and epigenetics of psychiatric diseases—volume II
por: Li, Qiyang, et al.
Publicado: (2022)

Familial Hypercholesterolemia in Russia: Three Decades of Genetic Studies
por: Vasilyev, Vadim, et al.
Publicado: (2020)

Aorta of young and middle-aged heterozygous familial hypercholesterolemia patients shows no functional or morphological impairment assessed by MRI
por: Soljanlahti, Sami, et al.
Publicado: (2008)

Sex Differences in Familial Hypercholesterolemia
por: Klevmoen, Marianne, et al.
Publicado: (2023)

Editorial: Network bioscience Volume II
por: Antoniotti, Marco, et al.
Publicado: (2023)

Fast and Easy Nanopore Sequencing Workflow for Rapid Genetic Testing of Familial Hypercholesterolemia
por: Soufi, Muhidien, et al.
Publicado: (2022)

Editorial: Bioinformatics of Genome Regulation, Volume II
por: Orlov, Yuriy L., et al.
Publicado: (2021)

Editorial: RNA modifications and epitranscriptomics, Volume II
por: Chen, Kunqi, et al.
Publicado: (2023)

Association of Familial Hypercholesterolemia and Statin Use With Risk of Dementia in Norway
por: Mundal, Liv J., et al.
Publicado: (2022)

The Prevalence and Genetic Spectrum of Familial Hypercholesterolemia in Qatar Based on Whole Genome Sequencing of 14,000 Subjects
por: Diboun, Ilhame, et al.
Publicado: (2022)

Editorial: Epigenetics in cancer: mechanisms and drug development-volume II
por: Zhu, Xiao, et al.
Publicado: (2023)

Effects of Different Types of Pathogenic Variants on Phenotypes of Familial Hypercholesterolemia
por: Tada, Hayato, et al.
Publicado: (2022)

PCSK9 Variants in Familial Hypercholesterolemia: A Comprehensive Synopsis
por: Guo, Qianyun, et al.
Publicado: (2020)

Two Novel Disease-Causing Mutations in the LDLR of Familial Hypercholesterolemia
por: Hu, Haochang, et al.
Publicado: (2021)

Implementation of a biochemical, clinical, and genetic screening programme for familial hypercholesterolemia in 26 centres in Spain: The ARIAN study
por: Arrobas Velilla, Teresa, et al.
Publicado: (2022)

Editorial: Novel Insights Into the Genetics of Growth Disorders
por: Giordano, Mara, et al.
Publicado: (2022)

Editorial: Machine Learning Techniques on Gene Function Prediction Volume II
por: Qi, Ren, et al.
Publicado: (2022)

Familial Hypercholesterolemia Prevalence Among Ethnicities—Systematic Review and Meta-Analysis
por: Toft-Nielsen, Frida, et al.
Publicado: (2022)

The Digenic Causality in Familial Hypercholesterolemia: Revising the Genotype–Phenotype Correlations of the Disease
por: Kamar, Amina, et al.
Publicado: (2021)

Genetic and Clinical Characteristics of Patients With Homozygous and Compound Heterozygous Familial Hypercholesterolemia From Three Different Populations: Case Series
por: Marusic, Tatiana, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hftsct30juicao0plrnpifgs0h